Innovid (NYSE:CTV – Get Free Report) had its price target lifted by research analysts at Morgan Stanley from $1.60 to $2.10 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price would suggest a potential downside of 9.09% from the company’s current price.
A number of other brokerages have also recently commented on CTV. Needham & Company LLC reaffirmed a “buy” rating and issued a $2.25 price target on shares of Innovid in a research note on Tuesday, February 27th. TheStreet raised Innovid from a “d” rating to a “c-” rating in a research note on Friday, March 15th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $3.00 price target on shares of Innovid in a research note on Wednesday, April 10th.
Check Out Our Latest Stock Analysis on CTV
Innovid Price Performance
Innovid (NYSE:CTV – Get Free Report) last released its earnings results on Tuesday, February 27th. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01). The company had revenue of $38.62 million during the quarter, compared to the consensus estimate of $36.90 million. Innovid had a negative return on equity of 8.92% and a negative net margin of 22.81%. During the same quarter in the previous year, the company posted ($0.03) EPS.
Insider Activity
In other Innovid news, CEO Zvika Netter bought 25,000 shares of Innovid stock in a transaction dated Wednesday, February 28th. The shares were purchased at an average cost of $1.84 per share, with a total value of $46,000.00. Following the completion of the purchase, the chief executive officer now owns 4,085,733 shares of the company’s stock, valued at $7,517,748.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 9.90% of the company’s stock.
Institutional Investors Weigh In On Innovid
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. bought a new stake in Innovid in the first quarter worth $38,000. Bank of New York Mellon Corp bought a new position in shares of Innovid during the first quarter valued at $118,000. Bank of Montreal Can bought a new position in shares of Innovid during the first quarter valued at $72,000. Vanguard Group Inc. bought a new position in shares of Innovid during the first quarter valued at $4,253,000. Finally, Lazard Asset Management LLC bought a new position in shares of Innovid during the first quarter valued at $41,000. 25.46% of the stock is owned by hedge funds and other institutional investors.
About Innovid
Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies.
Featured Articles
- Five stocks we like better than Innovid
- How to Choose Top Rated Stocks
- Silicon Motion Proves That AI in Motion Stays in Motion
- Profitably Trade Stocks at 52-Week Highs
- Undervalued UnitedHealth Group Won’t Be For Long
- 3 Monster Growth Stocks to Buy Now
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Innovid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovid and related companies with MarketBeat.com's FREE daily email newsletter.